- •1 The Normal Tear Film
- •3 Classification and Diagnosis of Dry Eye
- •4 Medical Management of Dry Eye Disease
- •5 Correction of Entropion and Ectropion
- •7 Lacrimal Drainage Surgery in a Patient with Dry Eyes
- •8 Surgery of the Conjunctiva
- •10 Keratoprosthesis Surgery
- •11 Eyelid Botulinum Toxin Injections for the Dry Eye
- •14 Mucous Membrane Grafting
- •15 Minor Salivary Gland Transplantation
- •17 Mechanical Pump Dacryoreservoirs
- •19 Animal Models of Dry Eye
- •20 Flow Chart on Surgical Approaches to Dry Eye
- •Author Index
- •Subject Index
Geerling G, Brewitt H (eds): Surgery for the Dry Eye.
Dev Ophthalmol. Basel, Karger, 2008, vol 41, pp 313–316
Flow Chart on Surgical Approaches to Dry Eye
Gerd Geerlinga, Horst Brewittb
aDepartment of Ophthalmology, University of Würzburg, Würzburg, Germany; bAugenklinik der Medizinischen Hochschule Hannover, Hannover, Germany
Abstract
Introduction: Based on the type and severity of dry eye, we propose a structured approach to the surgical management of the disease. Material and Methods: The guidelines for assessing the form and grade of dry eye as recently suggested by the ‘Dry Eye Workshop (DEWS)’. Flow chart on the surgical and medical management are presented. Results and Conclusion: Surgery should only be considered if any significant inflammation and concomitant adnexal disease has been controlled and medical management remains insufficient to control signs and symptoms of dry eye. The presence of signs of surface disease is considered mandatory. Although infrequent pre-existing occlusion of the lacrimal drainage system should be excluded, since this can also induce surface disease. The suggested sequence of treatment options makes use of less invasive procedures first while at the same time maximising efficacy and practicality. Often several measures have to be applied simultaneously to prevent loss of vision. Visual rehabilitation should only be attempted (e.g. by means of stem cell transplantation, keratoplasty). Once all concomittant factors have been addressed and measures to substitute the tear have been applied. In persisting aqueous deficiency osteoodontokeratoprosthesis remains the final option to improve visual function.
Copyright © 2008 S. Karger AG, Basel
The first steps in making a decision about the form of treatment consist of establishing the type as well as the severity of dry eye. The guidelines for both steps have recently been updated by a Dry Eye Workshop [DEWS manuscripts: The Ocular Surface] under the guidance of the Tear Film and Ocular Surface Society (TFOS). Since subjective symptoms and objective signs often differ significantly and since the diagnostic tool kit for dry eye suffers from some limitations of sensitivity and specificity, and hence repeatability, we proceed with surgery only if in addition to discomfort significant objective signs of ocular surface disease, e.g. fluorescein or rose bengal-positive staining or adnexal disorders
Mild to moderate symptoms and no signs
1 Episodic Mild to moderate conjunctival signs
Moderate to severe symptoms Tear film signs
2 Mild corneal punctate staining Chronic Conjunctival staining
Visual signs
Severe symptoms
3
Marked corneal punctate staining
Central corneal staining
Filamentary keratitis
Severe symptoms
4
Severe corneal staining
Erosions
Conjunctival scarring
Fig. 1. Management of dry eye as recently suggested by the ‘Dry Eye Workshop (DEWS)’.
such as lid margin malposition, lid retraction or exophthalmos are obvious. Although infrequent in this context, pre-existing occlusion of the lacrimal drainage system on the level of the nasolacrimal duct resulting in backwash of toxic cytokines should be excluded, since this can also induce surface disease.
The suggested sequence of treatment options is not obligatory, although it aims to use the less invasive procedures first while at the same time maximising efficacy and practicality (figs 1, 2). For example, punctal occlusion, especially if reversible, is more invasive than wearing scleral or limbal fit rigid contact lenses. However, it is also likely to be more practical for many patients.
Prior to any surgical attempt, inflammation of the ocular surface or adnexae should be controlled medically. Concomitant factors should also be excluded or – if present – treated first. Lid margin malposition (e.g. trichiasis, entropion, ectropion), lid retraction (e.g. due to thyroid disease or fornix shortening) and exophthalmos should be corrected. If the evaporative form of dry eye prevails, medical management including lid hygiene, topical anti-inflam- matory and systemic antibiotic treatment is common first-line treatment and tear substitutes should be used only as additive therapy. On the contrary, in aqueous deficiency, tear substitutes and subsequent occlusion of the lacrimal drainage are the obvious methods of first choice. If together with these measures contact lenses fail to relieve symptoms and signs of dry eye disease, then more invasive procedures such as minor salivary gland transplantation should be attempted. Only in the most severe cases, with severe visual impairment and discomfort recalcitrant to any other means should major salivary gland transplantation or implantation of a dacryoreservoir be considered.
Geerling/Brewitt |
314 |
Dry eye disease
(signs and symptoms present!)
Exclude and treat any exacerbating/concomitant disease
Lid margin malposition/lagophthalmos/exophthalmos
Exclude lacrimal drainage obstruction
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aqueous-deficient |
|
|
|
|
|
|
Evaporative |
||||||
dry eye |
|
|
|
|
|
|
dry eye |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tear substitutes |
|
|
|
|
|
|
Lid hygiene |
||||||
(including natural tear substitutes, e.g. serum) |
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary punctal occlusion |
|
|
|
|
|
Topical anti-inflammatory medication + antiseptic |
|||||||
(see flow chart in chapter 14) |
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scleral or limbal fit rigid contact lenses |
|
|
|
|
|
|
Systemic tetracycline |
||||||
|
|
|
|
|
|
derivatives |
|||||||
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minor salivary gland transplantation |
|
|
|
|
|
|
Tear substitutes |
||||||
|
|
|
|
|
(pharmaceutical products usually sufficient) |
||||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Major salivary gland transplantation or |
|
|
|
|
|
|
|
|
|
|
|
||
implantation of dacryoreservoir |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
Visual rehabilitation |
|
||||
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Correct excess lubrication |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
Stem cell transplantation |
||||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Keratoprosthesis (OOKP) |
|
|
|
(Lamellar) keratoplasty |
|||||
|
|
|
Only in aqueous-deficient dry eye |
|
|
|
|||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fig. 2. Flow chart on the surgical management of aqueous-deficient and evaporative dry eye.
Combinations of both forms of dry eye disease exist and if present require combined treatment. If the disease is mild to moderate with no threat of acute visual loss it is appropriate to take a stepwise approach and establish which means are and which are not effective. In more advanced disease with either severe discomfort or danger of loosing vision, several measures should be applied simultaneously.
Visual rehabilitation should only be attempted once all concomitant factors have been addressed appropriately and the above medical and surgical methods for substitution of the tear film have been successfully used. In the evaporative dry eye, limbal stem cell transplantation and/or corneal grafting, preferably as a
Flow Chart on Surgical Approaches to Dry Eye |
315 |
lamellar anterior keratoplasty to reduce the risk of endothelial rejection, are options. In persisting aqueous deficiency, osteoodontokeratoprosthesis remains the ultimate ratio to improve visual function.
Prof. Dr. Gerd Geerling
Klinik für Augenheilkunde, Julius-Maximilians-Universität Würzburg
Josef-Schneider-Str. 11, DE-97080 Würzburg (Germany)
Tel. 49 931 2012 0610, Fax 49 931 2012 0490
E-Mail g.geerling@augenklinik.uni-wuerzburg.de
Geerling/Brewitt |
316 |
